June 28, 2024
Director's Voice Blog
The Role of Behavioral and Social Sciences Research in NIH’s COVID-19 Response
It has been more than four years since the World Health Organization declared the COVID-19 outbreak a global pandemic. NIH initiatives highlighting behavioral and social sciences research included the NIH Community Engagement Alliance (CEAL) against COVID-19 disparities; an OBSSR-led administrative supplement on the impact of COVID-19 among women, children, and people with disabilities; and the Social, Behavioral, and Economic Impacts of COVID-19 in Vulnerable and Health Disparity Population Initiative (SBE COVID-19 Initiative), which OBSSR was proud to lead.
The SBE COVID-19 Initiative was a core part of NIH’s COVID-19 response, promoting research to improve predictions about various mitigation efforts, assess the health impacts of significant socioeconomic events, and evaluate digital and community-based interventions.
Events
NIH OBSSR Director’s Webinar—The Fabric of Aging in Mexico: Patterns and Potential
Join OBSSR on July 23, 2024, at 2:00 p.m. ET for a presentation by Dr. Rebeca Wong, who will explore the features of population aging in Mexico. She will discuss findings from the Mexican Health and Aging Study (MHAS), a 20+ year longitudinal study. Dr. Wong will examine evidence-based patterns in physical and cognitive function, chronic conditions, and social/economic resilience, highlighting the critical roles of childhood conditions, U.S. migration, employment, and family support in old age. Additionally, she will provide an overview of the pressing needs and potential for future research based on these themes.
This Director’s Webinar is a Norman B. Anderson Memorial Lecture. Norman B. Anderson, Ph.D., the first Director of OBSSR, was a pioneering figure in behavioral and social sciences research. In recognition of Dr. Anderson’s profound impact on behavioral and social sciences research, OBSSR hosts a lecture each year to honor his legacy.
NIH Workshop on How to Address the Impacts of Structural Racism on Health
NIH UNITE is convening researchers, clinicians, and community partners on July 18–19, 2024, for a workshop on Interdisciplinary Approaches to Understanding and Addressing Structural Racism and Health.
This virtual event will bring together researchers and clinicians in many fields—including social and natural sciences, law and criminal justice, education, public policy, and social work, as well as biomedical, behavioral, and public health—to identify recommendations for (1) addressing what is known about structural racism and health and (2) collaboratively approaching solutions.
News
Applications Are Now Open for the 2024-2025 NIH Climate and Health Scholars Program
The NIH Climate and Health Scholars Program seeks to bring climate and health scientists from outside the U.S. federal government to NIH to share their knowledge and expertise. The program’s goal is for climate and health scientists to support NIH in developing a stronger climate and health knowledge base in the areas of the NIH Climate Change and Health Initiative’s Strategic Framework.
OBSSR is seeking to host a scholar with expertise in the behavioral and social science factors underlying climate change adaptation, mitigation, or communication. The scholar may be health focused or may be a behavioral or social scientist with more broad expertise in climate change. Scholars with expertise in multilevel influences and methods, social determinants of health, and behavioral economics are encouraged to apply.
Applications are due by July 15, 2024. Please reach out to [email protected] with any questions.
NIH Releases Draft Public Access Policy and Draft Supplemental Guidance for Public Feedback
NIH is soliciting comments from the public on the NIH Draft Public Access Policy and two supplemental draft guidance documents regarding government use license and rights and costs for publications. The NIH Draft Public Access Policy builds upon NIH's long history of providing public access to scholarly publications resulting from the research it supports and proposes additional steps to accelerate access.
Public comments will be accepted until August 19, 2024. Questions may be sent to [email protected].
Now Available: Watch the 2024 NIH Matilda White Riley Behavioral and Social Science Honors
The 17th Matilda White Riley Behavioral and Social Sciences Honors is now available to view on demand. The annual event recognizes emerging scientists and leaders in the field whose research reflects Dr. Matilda White Riley’s vision of research excellence in health-related behavioral and social sciences.
Dr. White Riley, Ph.D., was a celebrated scientist and member of the National Academy of Sciences whose transformative work and leadership left a lasting impact on behavioral and social sciences across the National Institutes of Health (NIH) and beyond.
“Music as Medicine: The Science and Clinical Practice” Workshop Summaries and Video Recordings Now Available
The summaries and video recordings for the Music as Medicine: The Science and Clinical Practice workshop, which took place on December 14–15, 2023, are now available. These resources provide highlights of the accomplishments from the last 7 years in advancing scientific research on music and health, offer insights into the next phase of research, and serve to further build the research community.
OBSSR Director Jane M. Simoni, Ph.D., also discussed highlights from the workshop with Dr. Helene Langevin, Director of NIH’s National Center for Complementary and Integrative Health, in her January Director’s Voice blog.
Recently Published Funding Opportunities
Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
Next Application Due Date: July 5, 2024
Notice of Special Interest (NOSI): Improving Adherence to Treatment and Prevention Regimens and Maintenance of Health Behaviors to Promote Health
First Available Due Date: July 15, 2024
Topic Areas of Interest for Joint NIH/NSF Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise (SoS:BIO) Program
Next Application Due Date: September 9, 2024
NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed)
Next Application Due Date: October 8, 2024
BSSR Accomplishments
The NIH has been an instrumental leader in shaping and supporting behavioral and social sciences research (BSSR) to improve the nation’s health. Integrated with advances in other scientific disciplines, BSSR has made substantial contributions to the prevention or treatment of numerous physical health and mental health conditions.
In collaboration with subject matter experts from Institutes, Centers, and Offices across NIH, OBSSR has summarized some of the important scientific advances that demonstrate the valuable contribution of BSSR across various health conditions and behaviors. These summaries are provided as fact sheets that highlight a significant public health problem and the corresponding BSSR-informed approaches used to address the problem. Various audiences such as academic researchers, public health organizations, and other health federal agencies, may find these materials useful to demonstrate to their stakeholders the importance of BSSR to the health of the United States population.
BSSR Clinical Trials Resources
Clinical Trials Protocol Template for the Behavioral and Social Sciences
The Clinical Trials Protocol Template for the Behavioral and Social Sciences is a resource for communicating the science, methods, and operations of a clinical trial. This template is a suggested format for clinical trials that are testing a behavioral or social intervention or experimental manipulation. Use of the protocol template is encouraged but not required.
Decision Support Tool: Features to Consider in Determining If a Clinical Trial is Phase II or Phase III
This document is the result of a working group led by OBSSR, with participants from other Institutes, Centers, and Offices. It is a designed to be a resource to help investigators, program officers, and reviewers determine if a behavioral or social science study is better characterized as a Phase II or a Phase III clinical trial. Distinguishing earlier phases of clinical trials (Phase 0 or I) is not usually difficult but distinguishing between a Phase II and III study can be more challenging, particularly for non-drug trials. Being thoughtful about this distinction is important for a variety of reasons, not least of which is that a Phase III designation for an NIH funded clinical trial generally requires following additional policies and practices beyond those that already apply to Phase II clinical trials, such as the requirement for valid analysis and for a Data and Safety Monitoring Board (DSMB).
Good Clinical Practice for Social and Behavioral Research eLearning Course
In September 2016, the NIH issued a Policy on Good Clinical Practice (GCP) Training for NIH Awardees Involved in NIH-funded Clinical Trials. GCP is an international ethical and scientific quality standard for designing, conducting, recording, and reporting clinical trials. The principles of GCP help assure the safety, integrity, and quality of clinical trials.
Phase III Trials
NIH’s definition of a Phase III Clinical Trial is quite broad, including drug studies, device studies, behavioral interventions, epidemiological studies, community trials, and more. Phase III trials are usually large, prospective trials that compare two or more interventions against other standard or experimental interventions. In this next episode of our NIH All About Grants podcast (MP3 / Transcript) we explain what a Phase III trial is, how it compares to other types of clinical trials, considerations for your application and its review, how these studies influence standards of care, helpful tools and other resources, and much more.